In contrast to the mutual exclusivity of NOTCH1 and TERT promoter mutations in R/M ACC, there is a conspicuous co-occurrence of mutations in NOTCH1 and chromatin remodeling genes in these patients (particularly KDM6A, CREBBP, and ARID1A) [28]. This evidence concerns the gene CREBBP and adrenal cortex carcinoma.